Literature DB >> 25387567

Differential expression profiling of microRNAs in para-carcinoma, carcinoma and relapse human pancreatic cancer.

X-L Lai1, Y-H Huang, Y-S Li, G-N Li, L-P Wang, R Sun, Y-S Ma, S-Y Feng, Z-Y Chang, X-H Wang, D Fu, X Han, X-L Cong, W-P Li.   

Abstract

PURPOSE: To explore the altered different expression of miRNAs and the mechanisms underlying the relapse and metastasis of pancreatic cancer.
MATERIALS AND METHODS: The most differentially expressed miRNAs were analyzed by gene ontology (GO) term analysis, Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis and protein interaction analysis. The potentially regulated target genes of the most differentially expressed miRNAs were also analyzed further by GO term analysis and KEGG pathway analysis, and quantitated by qRT-PCR.
RESULTS: In total, we found 12 miRNAs displayed at least a 30-fold increase or decrease in expression of carcinoma and relapse vs. para-carcinoma human pancreatic cancer (C/R vs. P). In addition, our study found that pancreatic cancer was related to pathways in cancer, including Jak-STAT signaling pathway, MAPK signaling pathway and PPAR signaling pathway.
CONCLUSIONS: The differential expressed miRNAs and their predicted target genes that involved in Jak-STAT signaling pathway, MAPK signaling pathway and PPAR signaling pathway indicating their potential roles in pancreatic carcinogenesis and progress.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25387567     DOI: 10.1007/s12094-014-1249-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  28 in total

1.  Pesticide exposure and inherited variants in vitamin d pathway genes in relation to prostate cancer.

Authors:  Sara Karami; Gabriella Andreotti; Stella Koutros; Kathryn Hughes Barry; Lee E Moore; Summer Han; Jane A Hoppin; Dale P Sandler; Jay H Lubin; Laurie A Burdette; Jeffrey Yuenger; Meredith Yeager; Laura E Beane Freeman; Aaron Blair; Michael C R Alavanja
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-05       Impact factor: 4.254

2.  Differential gene expression of the key signalling pathway in para-carcinoma, carcinoma and relapse human pancreatic cancer.

Authors:  Zheng-Yan Chang; Ran Sun; Yu-Shui Ma; Da Fu; Xiao-Long Lai; Yu-Sheng Li; Xing-Hong Wang; Xiao-Ping Zhang; Zhong-Wei Lv; Xian-Ling Cong; Wen-Ping Li
Journal:  Cell Biochem Funct       Date:  2013-10-03       Impact factor: 3.685

3.  miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death.

Authors:  Caining Jin; Hasan Rajabi; Donald Kufe
Journal:  Int J Oncol       Date:  2010-07       Impact factor: 5.650

Review 4.  The role of cancer stem cells in cancer metastasis: new perspective and progress.

Authors:  Xiaofeng Wang; Yuzhen Zhu; Yushui Ma; Jin Wang; Feng Zhang; Qing Xia; Da Fu
Journal:  Cancer Epidemiol       Date:  2012-08-09       Impact factor: 2.984

5.  Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer.

Authors:  Rika Nishikawa; Yusuke Goto; Satoko Kojima; Hideki Enokida; Takeshi Chiyomaru; Takashi Kinoshita; Shinichi Sakamoto; Miki Fuse; Masayuki Nakagawa; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Int J Oncol       Date:  2014-05-09       Impact factor: 5.650

6.  Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.

Authors:  Shaan Sarkar; Hala Dubaybo; Shadan Ali; Priscila Goncalves; Sri Lakshmi Kollepara; Seema Sethi; Philip A Philip; Yiwei Li
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

7.  A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and TCEB1 genes are potential markers of progression.

Authors:  Laia Agell; Silvia Hernández; Lara Nonell; Marta Lorenzo; Eulàlia Puigdecanet; Silvia de Muga; Nuria Juanpere; Raquel Bermudo; Pedro L Fernández; José A Lorente; Sergio Serrano; Josep Lloreta
Journal:  Am J Pathol       Date:  2012-11       Impact factor: 4.307

8.  MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer.

Authors:  S Ali; H Saleh; S Sethi; F H Sarkar; P A Philip
Journal:  Br J Cancer       Date:  2012-08-28       Impact factor: 7.640

9.  MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9.

Authors:  Xiaofeng Chen; Jinrong Qiu; Dapeng Yang; Jianlei Lu; Caiyun Yan; Xiaoming Zha; Yongmei Yin
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

10.  Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients.

Authors:  Hui-chan He; Zhao-dong Han; Qi-shan Dai; Xiao-hui Ling; Xin Fu; Zhuo-yuan Lin; Ye-han Deng; Guo-qiang Qin; Chao Cai; Jia-hong Chen; Fu-neng Jiang; Xingyin Liu; Wei-de Zhong
Journal:  BMC Genomics       Date:  2013-11-05       Impact factor: 3.969

View more
  3 in total

1.  MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.

Authors:  Yuan Yu; Lei Liu; Ruirui Ma; Haibing Gong; Ping Xu; Congjun Wang
Journal:  Tumour Biol       Date:  2016-08-29

2.  MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1α) in the tumor microenvironments.

Authors:  Yebin Lu; Niandong Ji; Wei Wei; Weijia Sun; Xuejun Gong; Xitao Wang
Journal:  Biol Open       Date:  2017-02-15       Impact factor: 2.422

3.  Differential expression of microRNAs in xenografted Lewis lung carcinomas subjected to intermittent hypoxia: a next-generation sequence analysis.

Authors:  Xiao-Bin Zhang; Xiu-Li Lin; Xin-Yu Wu; Yi-Ming Zeng; Xiao-Yang Chen; Xiongbiao Luo; Hui-Qing Zeng
Journal:  Transl Cancer Res       Date:  2020-07       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.